ATHA
Price
$4.76
Change
+$0.16 (+3.48%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
18.14M
Intraday BUY SELL Signals
AURA
Price
$5.39
Change
-$0.02 (-0.37%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
343.55M
132 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATHA vs AURA

Header iconATHA vs AURA Comparison
Open Charts ATHA vs AURABanner chart's image
Athira Pharma
Price$4.76
Change+$0.16 (+3.48%)
Volume$100
Capitalization18.14M
Aura Biosciences
Price$5.39
Change-$0.02 (-0.37%)
Volume$1.9K
Capitalization343.55M
ATHA vs AURA Comparison Chart in %
ATHA
Daily Signal:
Gain/Loss:
AURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ATHA vs. AURA commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Hold and AURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ATHA: $4.60 vs. AURA: $5.41)
Brand notoriety: ATHA and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 28% vs. AURA: 61%
Market capitalization -- ATHA: $18.14M vs. AURA: $343.55M
ATHA [@Biotechnology] is valued at $18.14M. AURA’s [@Biotechnology] market capitalization is $343.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileAURA’s FA Score has 1 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • AURA’s FA Score: 1 green, 4 red.
According to our system of comparison, ATHA is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 6 TA indicator(s) are bullish while AURA’s TA Score has 3 bullish TA indicator(s).

  • ATHA’s TA Score: 6 bullish, 3 bearish.
  • AURA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ATHA is a better buy in the short-term than AURA.

Price Growth

ATHA (@Biotechnology) experienced а -0.54% price change this week, while AURA (@Biotechnology) price change was -4.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.80%.

Reported Earning Dates

AURA is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($344M) has a higher market cap than ATHA($18.1M). ATHA YTD gains are higher at: -21.595 vs. AURA (-34.185). ATHA has higher annual earnings (EBITDA): -56.92M vs. AURA (-107.51M). ATHA has less debt than AURA: ATHA (1.02M) vs AURA (18.1M). ATHA (0) and AURA (0) have equivalent revenues.
ATHAAURAATHA / AURA
Capitalization18.1M344M5%
EBITDA-56.92M-107.51M53%
Gain YTD-21.595-34.18563%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A177M-
Total Debt1.02M18.1M6%
TECHNICAL ANALYSIS
Technical Analysis
ATHAAURA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATHA
Daily Signal:
Gain/Loss:
AURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ILKAF4.430.20
+4.73%
Iluka Resources Ltd.
DCYHY26.80N/A
N/A
Discovery Holdings Ltd.
RUBLF1.71N/A
-0.18%
Rubellite Energy Corp.
LRLCY81.50-0.40
-0.49%
L'Oreal Co.
TBTC3.80-0.02
-0.52%
Table Trac, Inc.

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with ALGS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then ALGS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
N/A
ALGS - ATHA
37%
Loosely correlated
+14.10%
ALNY - ATHA
35%
Loosely correlated
+0.38%
OGEN - ATHA
35%
Loosely correlated
-2.47%
AURA - ATHA
34%
Loosely correlated
-1.64%
MGNX - ATHA
34%
Loosely correlated
+2.32%
More